Collette Coll

Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom.

Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia.

KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.

Oxitec Ltd. develops solutions for controlling harmful insect pests. It provides biological and development research services in controlling insects that spread diseases and damage crops. Its products include Diamond back moth, Pink bollworm, Medfl,y Mexfly, and Olive fly. The company was founded by Luke Alphey on August 15, 2002 and is headquartered in Abingdon, the United Kingdom.

KDB Infrastructure Investments Asset Management Co., Ltd. (KIAMCO) is the private equity subsidiary of KDB Financial Group Inc, founded in 2003. The firm is headquartered in Seoul, South Korea.

Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey.

BYOMass, Inc. provides investment holding services. The company is headquartered in Sudbury, MA.

Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States.

Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom.

Kleo Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of biospecific compounds designed to emulate and enhance the activity of biologics. Its compounds are designed to direct the immune system to destroy cancerous or virally infected cells, and treatment of multiple myeloma and COVID-19. It offers Antibody Recruiting Molecules (ARMs),Synthetic Antibody Mimics (SyAMs), and Monoclonal Antibody Therapy Enhancers (MATEs) pipeline. The company was founded by David A. Spiegel and Roy Prieb in 2015 and is headquartered in New Haven, CT.

iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom.

Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.

The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK.

Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million.

Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ.

OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom.

Valiance Life Science Investments (Valiance Life Science Investments) is a private equity subsidiary of Valiance Asset Management Ltd. founded in 2017. The firm headquartered in London, United Kingdom.

BibliU Ltd. operates an online platform that provides students with access to their textbooks and libraries with affordable core textbook packages. The company was founded by Dave Sherwood, Ellis Gecan, Tao Mantaras and Daniel Engelke and is headquartered in London, the United Kingdom.

Opsydia Ltd. manufactures and distributes laser cutting machinery. Its applications include diamond, media and sensors. The company was founded by Patrick Salter and Martin Booth in September 2017 and is headquartered in Begbroke, the United Kingdom.

Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom.

Metaboards Ltd. manufactures magneto devices and develops software application. It specializes in medical devices, consumer electronics, aerospace and defence, clothing and fabrics. The company was founded by Ekaterina Shamonina and is headquartered in Oxford, the United Kingdom.

Proxisense Ltd. develops proximity sensors and fluid contamination systems for use in extreme environments. The company was founded on September 16, 2014 and is headquartered in Haslemere, the United Kingdom.

Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom.

Enzbond Ltd. engages in research and development on natural sciences and engineering. The firm specializes in enzyme discovery. The company was founded by Alina Rakhimova and Robert Simion and is headquartered in Oxford, the United Kingdom.

CIRCADIAN Therapeutics Ltd. develops drugs that derive therapeutic effects through modulation of the control of sleep and circadian rhythm. The company was founded by Chris Blackwell, Russell Foster, Maarten De Vos, A. Jagannath, and S. Vasudevanis on July 18, 2016 and is headquartered in Oxford, the United Kingdom.

Nordic Capital Ltd. (Nordic Capital) is a private equity subsidiary of Triona Holding SA founded in 1989 by Robert Andreen and Morgan Olsson. The firm is headquartered in St Hellier, New Jersey.

Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom.

Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy.

Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA.

Pavilion Data Systems, Inc. designs and develops NVMe-oF storage technologies. Its NVMe-over-Fabric Storage Array ingests, processes, stores, and serves an order of magnitude more data for massively-parallel, modern applications. The company was founded by Kiran Malwankar, V. R. Satish, and Sundar Kanthadai in 2014 and is headquartered in San Jose, CA.

Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom.

PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France.

Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden.